Variant report

Variant	nsv3253
Chromosome Location	chr20:1547092-1603832
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:371)
CpG islands
(count:306)
Chromatin interactive
region (count:1)
LncRNA
region (count:5)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:371 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr20:1550229-1550409	K562	blood:	n/a	n/a
2	ATF1	chr20:1597810-1598006	K562	blood:	n/a	n/a
3	ATF1	chr20:1550073-1550394	K562	blood:	n/a	n/a
4	ATF2	chr20:1603058-1603543	GM12878	blood:	n/a	n/a
5	BACH1	chr20:1550102-1550372	K562	blood:	n/a	n/a
6	BATF	chr20:1603174-1603482	GM12878	blood:	n/a	n/a
7	BCL11A	chr20:1603100-1603339	GM12878	blood:	n/a	n/a
8	BCL11A	chr20:1603111-1603444	GM12878	blood:	n/a	n/a
9	BCL3	chr20:1603087-1603515	GM12878	blood:	n/a	n/a
10	BCLAF1	chr20:1603036-1603400	GM12878	blood:	n/a	n/a
11	BHLHE40	chr20:1549969-1550250	K562	blood:	n/a	n/a
12	BHLHE40	chr20:1603122-1603445	GM12878	blood:	n/a	n/a
13	BRCA1	chr20:1603218-1603418	GM12878	blood:	n/a	n/a
14	BRCA1	chr20:1550123-1550444	Hela-S3	cervix:	n/a	n/a
15	CEBPB	chr20:1596225-1596242	HepG2	liver:	n/a	n/a
16	CEBPB	chr20:1550121-1550426	IMR90	lung:	n/a	n/a
17	CEBPB	chr20:1557313-1557606	Hela-S3	cervix:	n/a	chr20:1557460-1557471
18	CEBPB	chr20:1600640-1600781	HepG2	liver:	n/a	chr20:1600734-1600745
19	CEBPB	chr20:1550085-1550450	A549	lung:	n/a	n/a
20	CEBPB	chr20:1550069-1550318	K562	blood:	n/a	n/a
21	CEBPB	chr20:1549993-1550495	Hela-S3	cervix:	n/a	n/a
22	CEBPB	chr20:1550076-1550409	HepG2	liver:	n/a	n/a
23	CEBPB	chr20:1549987-1550512	A549	lung:	n/a	n/a
24	CEBPB	chr20:1548089-1548620	Hela-S3	cervix:	n/a	n/a
25	CEBPB	chr20:1549872-1550575	HCT-116	colon:	n/a	chr20:1549945-1549956
26	CEBPB	chr20:1557320-1557574	A549	lung:	n/a	chr20:1557460-1557471
27	CEBPB	chr20:1549828-1550670	HCT-116	colon:	n/a	chr20:1549945-1549956
28	CEBPB	chr20:1550079-1550429	K562	blood:	n/a	n/a
29	CEBPB	chr20:1557318-1557553	HepG2	liver:	n/a	chr20:1557460-1557471
30	CEBPB	chr20:1550062-1550405	A549	lung:	n/a	n/a
31	CEBPB	chr20:1550060-1550411	MCF-7	breast:	n/a	n/a
32	CHD1	chr20:1600268-1600351	GM12878	blood:	n/a	n/a
33	CHD1	chr20:1601432-1601474	GM12878	blood:	n/a	n/a
34	CHD2	chr20:1548232-1548651	Hela-S3	cervix:	n/a	n/a
35	CHD2	chr20:1603157-1603427	GM12878	blood:	n/a	n/a
36	CHD2	chr20:1550074-1550408	Hela-S3	cervix:	n/a	n/a
37	CHD2	chr20:1600141-1600445	GM12878	blood:	n/a	n/a
38	CREB1	chr20:1550008-1550399	K562	blood:	n/a	n/a
39	CTCF	chr20:1569820-1569970	AG10803	skin:	n/a	n/a
40	CTCF	chr20:1569844-1569973	GM12878	blood:	n/a	n/a
41	CTCF	chr20:1556774-1556880	NHEK	skin:	n/a	n/a
42	CTCF	chr20:1569840-1569990	HRE	kidney:	n/a	n/a
43	CTCF	chr20:1569820-1569970	HEEpiC	esophagus:	n/a	n/a
44	CTCF	chr20:1569840-1569990	HRPEpiC	eye:	n/a	n/a
45	CTCF	chr20:1583954-1584054	GM19239	blood:	n/a	chr20:1583996-1584006
46	CTCF	chr20:1583993-1584014	H1-hESC	embryonic stem cell:	n/a	chr20:1583996-1584006
47	CTCF	chr20:1599200-1599350	NB4	blood:	n/a	n/a
48	CTCF	chr20:1569860-1570007	GM12878	blood:	n/a	n/a
49	CTCF	chr20:1550540-1550690	NB4	blood:	n/a	n/a
50	CTCF	chr20:1569860-1570010	HEEpiC	esophagus:	n/a	n/a

(count:306 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr20:1601704-1601754	Hela-S3	cervix:	n/a
2	chr20:1601704-1601754	Hela-S3	cervix:	n/a
3	chr20:1600705-1600755	AG04449	skin:	fetal
4	chr20:1600641-1600691	Hepatocyte	liver:	n/a
5	chr20:1601704-1601754	K562	blood:	n/a
6	chr20:1600641-1600691	HAEpiC	amniotic membrane:	n/a
7	chr20:1601704-1601754	ProgFib	skin:	n/a
8	chr20:1600705-1600755	AG09319	gingival:	n/a
9	chr20:1601704-1601754	HL-60	blood:	n/a
10	chr20:1600623-1600673	NH-A	brain:	n/a
11	chr20:1600641-1600691	AG10803	skin:	n/a
12	chr20:1601704-1601754	NHDF-neo	bronchial:	n/a
13	chr20:1578550-1578600	NH-A	brain:	n/a
14	chr20:1600705-1600755	HRPEpiC	eye:	n/a
15	chr20:1600623-1600673	NHDF-neo	bronchial:	n/a
16	chr20:1600623-1600673	HNPCEpiC	eye:	n/a
17	chr20:1600641-1600691	H1-hESC	embryonic stem cell:	embryo
18	chr20:1601704-1601754	SK-N-SH	brain:	n/a
19	chr20:1601704-1601754	HRE	kidney:	n/a
20	chr20:1600705-1600755	U87	brain:	n/a
21	chr20:1578550-1578600	HAEpiC	amniotic membrane:	n/a
22	chr20:1601704-1601754	AG04449	skin:	fetal
23	chr20:1600705-1600755	K562	blood:	n/a
24	chr20:1600623-1600673	SK-N-SH	brain:	n/a
25	chr20:1578550-1578600	AoSMC	blood vessel:	n/a
26	chr20:1600705-1600755	IMR90	lung:	fetal
27	chr20:1600641-1600691	MCF10A-Er-Src	breast:	n/a
28	chr20:1600705-1600755	HRCEpiC	kidney:	n/a
29	chr20:1601704-1601754	AG09309	skin:	n/a
30	chr20:1601704-1601754	BJ	skin:	n/a
31	chr20:1600641-1600691	SKMC	muscle:	n/a
32	chr20:1600641-1600691	HCM	heart:	n/a
33	chr20:1578550-1578600	HCF	heart:	n/a
34	chr20:1601704-1601754	ECC-1	luminal epithelium:	n/a
35	chr20:1600705-1600755	AoSMC	blood vessel:	n/a
36	chr20:1578550-1578600	SK-N-MC	brain:	n/a
37	chr20:1600623-1600673	H1-hESC	embryonic stem cell:	embryo
38	chr20:1578550-1578600	GM06990	blood:	n/a
39	chr20:1600641-1600691	NB4	blood:	n/a
40	chr20:1600705-1600755	HCM	heart:	n/a
41	chr20:1601704-1601754	HIPEpiC	eye:	n/a
42	chr20:1600641-1600691	Hela-S3	cervix:	n/a
43	chr20:1600623-1600673	LNCaP	prostate:	n/a
44	chr20:1600705-1600755	RPTEC	kidney:	n/a
45	chr20:1578550-1578600	U87	brain:	n/a
46	chr20:1578550-1578600	HCM	heart:	n/a
47	chr20:1578550-1578600	Jurkat	blood:	n/a
48	chr20:1601704-1601754	HCT-116	colon:	n/a
49	chr20:1600705-1600755	GM12892	blood:	n/a
50	chr20:1600623-1600673	AG09319	gingival:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr20:1547054..1548894-chr20:1756067..1757690,2	K562	blood:

(count:5 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SNPH-4	chr20:1572038-1572494	NONHSAT078121
2	lnc-SNPH-5	chr20:1562154-1562366	ucscGeneNc_uc002wfp_1
3	lnc-SNPH-5	chr20:1559583-1559595	ucscGeneNc_uc002wfp_1
4	lnc-SNPH-5	chr20:1574682-1577118	ucscGeneNc_uc002wfp_1
5	lnc-SNPH-5	chr20:1565852-1565996	ucscGeneNc_uc002wfp_1

No data

Variant related genes	Relation type
SIRPB1	TF binding region
ENSG00000260861	TF binding region
ENSG00000271523	TF binding region
SIRPB1	CpG island
ENSG00000260861	CpG island
ENSG00000271523	CpG island

Extended variants
information (count: 1376 )
Associated
traits (count: 70 )

Variant overlapped rSNPs/rCNVs (count:1376 , 50 per page) page: 1 2 3 4 5 6 7 ... 28

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs532539136	chr20:1547092-1547093	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs61741656	chr20:1547124-1547125	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs541176866	chr20:1547161-1547162	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs559852954	chr20:1547176-1547177	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs558134045	chr20:1547183-1547184	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs114854215	chr20:1547212-1547213	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs4814327	chr20:1547213-1547214	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs375022301	chr20:1547220-1547221	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs563626229	chr20:1547238-1547239	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs35048020	chr20:1547241-1547242	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs79248427	chr20:1547251-1547252	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs549365414	chr20:1547258-1547259	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs564545322	chr20:1547260-1547261	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs532028783	chr20:1547297-1547298	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs78484958	chr20:1547325-1547326	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs186759706	chr20:1547345-1547346	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs530529957	chr20:1547356-1547357	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs149584679	chr20:1547424-1547425	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs536042216	chr20:1547436-1547437	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs548391858	chr20:1547554-1547555	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs56045824	chr20:1547584-1547585	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs369123054	chr20:1547594-1547595	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs567241630	chr20:1547608-1547609	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs202100457	chr20:1547648-1547649	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs534214608	chr20:1547684-1547685	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs79421370	chr20:1547690-1547691	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs190753789	chr20:1547704-1547705	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs138812104	chr20:1547713-1547714	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs558952226	chr20:1547740-1547741	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs200219407	chr20:1547741-1547742	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs75930333	chr20:1547742-1547743	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs553207708	chr20:1547751-1547752	Enhancers Genic enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs187690792	chr20:1547836-1547837	Enhancers Genic enhancers Strong transcription Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs542038419	chr20:1547857-1547858	Enhancers Genic enhancers Strong transcription Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs553208540	chr20:1547889-1547890	Enhancers Genic enhancers Strong transcription Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs566690767	chr20:1547919-1547920	Enhancers Genic enhancers Strong transcription Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs563589229	chr20:1547930-1547931	Enhancers Genic enhancers Strong transcription Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs368663844	chr20:1547936-1547937	Enhancers Genic enhancers Strong transcription Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs141907065	chr20:1547958-1547959	Enhancers Genic enhancers Strong transcription Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs546088528	chr20:1547961-1547962	Enhancers Genic enhancers Strong transcription Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs74553185	chr20:1547982-1547983	Enhancers Genic enhancers Strong transcription Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs532025900	chr20:1548005-1548006	Enhancers Genic enhancers Weak transcription Strong transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs75945529	chr20:1548112-1548113	Enhancers Genic enhancers Weak transcription Strong transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs367615615	chr20:1548129-1548130	Enhancers Genic enhancers Weak transcription Strong transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs559161622	chr20:1548168-1548169	Enhancers Genic enhancers Weak transcription Strong transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs146033200	chr20:1548217-1548218	Enhancers Genic enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
47	rs139953393	chr20:1548229-1548230	Enhancers Genic enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
48	rs190783417	chr20:1548256-1548257	Enhancers Genic enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
49	rs538799697	chr20:1548258-1548259	Enhancers Genic enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
50	rs530779696	chr20:1548261-1548262	Enhancers Genic enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:70)

Disease	PMID	Source
Hodgkin''s lymphoma	18641027	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	22045946	CNVD
Glioblastoma multiforme	22286061	CNVD
Hepatocellular carcinoma	22174799	CNVD
Colorectal cancer	19455253	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17603634	CNVD
Colorectal cancer	19359472	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Intracranial aneurysm	16715129	CNVD
Colorectal cancer	16774939	CNVD
Autism	18414403	CNVD
Neurocytoma	17123091	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16397240	CNVD
abortions and stillbirths	19751515	CNVD
Wilms tumour	21544195	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	16272173	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	19627613	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Central neurocytomas	17123091	CNVD
Colorectal cancer	16272173	CNVD
Gastric cancer	17908304	CNVD
Urothelial carcinoma	21177765	CNVD
lymphocytic leukemia	21291569	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Colorectal cancer	21645411	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	17363583	CNVD
Non-syndromic sensorineural hearing loss	17289997	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Prostate cancer	21551127	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Alcoholism	21790672	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:346 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr20:1537000-1551600	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
2	chr20:1543200-1550400	Weak transcription	Thymus	Thymus
3	chr20:1543600-1548600	Genic enhancers	Primary monocytes fromperipheralblood	blood
4	chr20:1543800-1568000	Weak transcription	Primary T helper cells PMA-I stimulated	--
5	chr20:1544600-1569000	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
6	chr20:1544800-1548200	Strong transcription	Primary mononuclear cells fromperipheralblood	Blood
7	chr20:1545000-1548000	Strong transcription	Primary neutrophils fromperipheralblood	blood
8	chr20:1545200-1547400	Strong transcription	Primary T cells from cord blood	blood
9	chr20:1545800-1549400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
10	chr20:1546200-1547800	Strong transcription	Monocytes-CD14+_RO01746	blood
11	chr20:1546600-1551200	Enhancers	Hela-S3	cervix
12	chr20:1546600-1551400	Weak transcription	Spleen	Spleen
13	chr20:1546800-1550800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
14	chr20:1546800-1551000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
15	chr20:1547000-1547800	Enhancers	NHEK	skin
16	chr20:1547000-1550800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
17	chr20:1547000-1551000	Enhancers	HMEC	breast
18	chr20:1547200-1549000	Enhancers	NH-A	brain
19	chr20:1547200-1549400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
20	chr20:1547200-1551000	Enhancers	HUVEC	blood vessel
21	chr20:1547400-1548000	Enhancers	A549	lung
22	chr20:1547400-1548800	Weak transcription	Primary T cells from cord blood	blood
23	chr20:1547400-1549000	Enhancers	Osteobl	bone
24	chr20:1547800-1548000	Genic enhancers	Monocytes-CD14+_RO01746	blood
25	chr20:1547800-1548200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
26	chr20:1547800-1548600	Enhancers	HUES64 Cell Line	embryonic stem cell
27	chr20:1547800-1548800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
28	chr20:1547800-1548800	Flanking Active TSS	NHEK	skin
29	chr20:1547800-1550200	Enhancers	NHDF-Ad	bronchial
30	chr20:1548000-1548200	Active TSS	A549	lung
31	chr20:1548000-1548400	Enhancers	HUES6 Cell Line	embryonic stem cell
32	chr20:1548000-1548400	Genic enhancers	Primary neutrophils fromperipheralblood	blood
33	chr20:1548000-1548400	Enhancers	Esophagus	oesophagus
34	chr20:1548000-1548400	Enhancers	NHLF	lung
35	chr20:1548000-1548800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
36	chr20:1548000-1549000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
37	chr20:1548000-1549000	Enhancers	Muscle Satellite Cultured Cells	--
38	chr20:1548000-1549000	Transcr. at gene 5' and 3'	Monocytes-CD14+_RO01746	blood
39	chr20:1548200-1548600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
40	chr20:1548200-1548600	Flanking Active TSS	A549	lung
41	chr20:1548200-1551400	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
42	chr20:1548400-1548600	Enhancers	ES-I3 Cell Line	embryonic stem cell
43	chr20:1548400-1548800	Weak transcription	Esophagus	oesophagus
44	chr20:1548400-1550200	Enhancers	Primary neutrophils fromperipheralblood	blood
45	chr20:1548600-1549000	Enhancers	Primary hematopoietic stem cells	blood
46	chr20:1548600-1550600	Enhancers	Primary monocytes fromperipheralblood	blood
47	chr20:1548600-1550600	Enhancers	A549	lung
48	chr20:1548800-1549000	Enhancers	Esophagus	oesophagus
49	chr20:1548800-1551000	Enhancers	Primary hematopoietic stem cells short term culture	blood
50	chr20:1548800-1551000	Enhancers	NHEK	skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links